Breaking News Instant updates and real-time market news.

2020-06-09 12:17:07 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 12:17 06/09/20 06/09 12:17 06/09/20 12:17	NASDAQ market internals summary Volume is above average for this time of day. Breadth is mixed with issues and volume bearish while new highs to new lows are bullish (positive divergence). Advancing Issues: 941 / Declining Issues: 2290 -- for a ratio of 0.4 to 1. Advancing Volume: 1,142,530,000 / Declining Volume: 1,405,413,000 -- for a ratio of 0.8 to 1. New 52-Week Highs: 57 / New 52-Week Lows: 2.

2020-06-09 12:17:07

$NSD

NASDAQ Market Internals

$0.00 / + (+0.00%)

12:17

06/09/20

06/09

12:17

06/09/20

12:17

NASDAQ market internals summary

Volume is above average for this time of day. Breadth is mixed with issues and volume bearish while new highs to new lows are bullish (positive divergence). Advancing Issues: 941 / Declining Issues: 2290 -- for a ratio of 0.4 to 1. Advancing Volume: 1,142,530,000 / Declining Volume: 1,405,413,000 -- for a ratio of 0.8 to 1. New 52-Week Highs: 57 / New 52-Week Lows: 2.

TODAY'S FREE FLY STORIES

Downgrade	Roche downgraded to Hold from Buy at Erste Group » 05:20 03/05/21 03/05 05:20 03/05/21 05:20 RHHBY Roche $0.00 / + (+0.00%) Erste Group analyst Hans… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events RHHBY Roche $0.00 / + (+0.00%) 03/04/21 Genentech's Acterma approved by FDA for regulating pulmonary function in SSc-ILD 03/04/21 Dicerna, Roche begin combo trial of GalXC for chronic HBV treatment 03/03/21 Adaptive says Genentech suspends development of shared antigen target candidate 02/26/21 Regeneron announces CHMP recommendation for COVID-19 antibody cocktail RHHBY Roche $0.00 / + (+0.00%) 03/03/21 Goldman Sachs Adaptive Biotechnologies downgraded to Neutral from Buy at Goldman Sachs 02/25/21 Berenberg Roche price target lowered to CHF 320 from CHF 325 at Berenberg 02/24/21 Morgan Stanley Roche price target lowered to CHF 345 from CHF 365 at Morgan Stanley 02/23/21 BofA BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list RHHBY Roche $0.00 / + (+0.00%) 02/04/21 Roche reports 2020 core EPS CHF 19.16 vs. CHF 20.16 last year 10/27/20 Oncolytics announces new GI cancer study using 10/15/20 Roche confirms outlook for 2020 based on assessment of COVID-19 10/15/20 Roche reports 9 months group sales CHF43.98B vs. CHF46.07B last year RHHBY Roche $0.00 / + (+0.00%) 02/11/21 Roche arthritis drug reduced Covid deaths in study, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports RHHBY Roche $0.00 / + (+0.00%) 12/26/20 Week in review: How Trump's policies moved stocks 11/30/20 Fly Intel: Wall Street's top stories for Monday 11/30/20 Fly Intel: Wall Street's top stories at midday 11/21/20 Week in review: How Trump's policies moved stocks 03/25/21 Roche - RHHBY
Upgrade	Amadeus IT Group upgraded to Buy from Hold at Erste Group » 05:20 03/05/21 03/05 05:20 03/05/21 05:20 AMADY Amadeus IT Group $0.00 / + (+0.00%) Erste Group analyst Hans… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research AMADY Amadeus IT Group $0.00 / + (+0.00%) 02/26/21 Microsoft, Amadeus IT Group announce strategic partnership AMADY Amadeus IT Group $0.00 / + (+0.00%) 03/02/21 UBS Amadeus IT Group price target lowered to EUR 61 from EUR 65 at UBS 03/01/21 JPMorgan Amadeus IT Group price target raised to EUR 58 from EUR 50 at JPMorgan 03/01/21 Oddo BHF Amadeus IT Group upgraded to Neutral from Reduce at Oddo BHF 03/01/21 Oddo BHF Amadeus IT Group upgraded to Neutral from Reduce at Oddo BHF
Initiation	Cadeler initiated with a Buy at Kepler Cheuvreux » 05:19 03/05/21 03/05 05:19 03/05/21 05:19 CADLF Cadeler $0.00 / + (+0.00%) Kepler Cheuvreux… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CADLF Cadeler $0.00 / + (+0.00%) 01/06/21 DNB Markets Cadeler initiated with a Buy at DNB Markets
Earnings	GSX Techedu reports Q4 EPS (39c), consensus (38c) » 05:19 03/05/21 03/05 05:19 03/05/21 05:19 GSX GSX Techedu $84.11 / -2.9 (-3.33%) Reports Q4 revenue… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GSX GSX Techedu $84.11 / -2.9 (-3.33%) 03/03/21 GSX Techedu falls -13.3% 01/13/21 GSX Techedu rises 27.1% 12/07/20 GSX Techedu rises 15.3% 11/23/20 GSX 'as close as possible' to being proven fraud before delisting, Block says GSX GSX Techedu $84.11 / -2.9 (-3.33%) 02/01/21 JPMorgan GSX Techedu downgraded to Underweight from Neutral at JPMorgan 01/29/21 GSX Techedu downgraded to Sell from Neutral at China Merchants 01/28/21 Goldman Sachs GSX Techedu downgraded to Sell from Neutral at Goldman Sachs 12/17/20 Fly Intel: Top five analyst downgrades GSX GSX Techedu $84.11 / -2.9 (-3.33%) 11/20/20 GSX Techedu reports Q3 EPS (57c), consensus (31c) GSX GSX Techedu $84.11 / -2.9 (-3.33%) 12/18/20 Seven whistleblowers have described 'fraud' at GSX Techedu, Aurelius Value says 10/12/20 WSJ article on GSX 'somewhat misses the point,' Muddy Waters says 10/12/20 GSX proves to be one of the year's worst short bets, WSJ says GSX GSX Techedu $84.11 / -2.9 (-3.33%) 02/01/21 Fly Intel: Pre-market Movers 01/28/21 Fly Intel: Wall Street's top stories for Thursday 01/28/21 Fly Intel: Wall Street's top stories at midday 11/20/20 Fly Intel: Wall Street's top stories for Friday 08:00 Today GSX Techedu - GSX GSX GSX Techedu $84.11 / -2.9 (-3.33%) 03/04/21 GSX Techedu put volume heavy and directionally bearish 03/03/21 GSX Techedu put volume heavy and directionally bearish 01/21/21 GSX Techedu call volume above normal and directionally bullish 12/28/20 GSX Techedu put volume heavy and directionally bearish
Upgrade	AXA upgraded to Conviction Buy from Buy at Bryan Garnier » 05:19 03/05/21 03/05 05:19 03/05/21 05:19 AXAHY AXA $0.00 / + (+0.00%) Bryan Garnier analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Periodicals AXAHY AXA $0.00 / + (+0.00%) 03/03/21 Deutsche Bank AXA price target raised to EUR 25 from EUR 24.50 at Deutsche Bank 03/02/21 Morgan Stanley AXA price target lowered to EUR 24 from EUR 24.20 at Morgan Stanley 03/01/21 Berenberg AXA price target raised to EUR 23.30 from EUR 21.50 at Berenberg 02/26/21 RBC Capital AXA price target raised to EUR 24 from EUR 23 at RBC Capital AXAHY AXA $0.00 / + (+0.00%) 02/24/21 Baker Hughes, AXA, 16 others wind down work on Nord Stream 2, Reuters says 09/24/20 Allianz and Athora in talks for joint bid for Aviva's French unit, Reuters says

Upgrade	Meggitt upgraded to Outperform from Neutral at Exane BNP Paribas » 05:18 03/05/21 03/05 05:18 03/05/21 05:18 MEGGF Meggitt $0.00 / + (+0.00%) Exane BNP Paribas analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research MEGGF Meggitt $0.00 / + (+0.00%) 02/11/21 Morgan Stanley Meggitt price target lowered to 455 GBp from 465 GBp at Morgan Stanley 02/04/21 Jefferies Meggitt price target raised to 500 GBp from 375 GBp at Jefferies 01/08/21 JPMorgan Meggitt price target lowered to 390 GBp from 395 GBp at JPMorgan 12/15/20 Panmure Gordon Meggitt downgraded to Sell from Hold at Panmure Gordon
Upgrade	Woodside Petroleum upgraded to Overweight from Neutral at JPMorgan » 05:17 03/05/21 03/05 05:17 03/05/21 05:17 WOPEY Woodside Petroleum $0.00 / + (+0.00%) JPMorgan analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research WOPEY Woodside Petroleum $0.00 / + (+0.00%) 12/09/20 JPMorgan Woodside Petroleum downgraded to Neutral from Overweight at JPMorgan 07/17/20 Citi Woodside Petroleum downgraded to Neutral from Buy at Citi 06/25/20 JPMorgan Woodside Petroleum upgraded to Overweight from Neutral at JPMorgan 05/05/20 Bernstein Woodside Petroleum upgraded to Outperform from Market Perform at Bernstein
Downgrade	Brembo downgraded to Reduce from Hold at Kepler Cheuvreux » 05:16 03/05/21 03/05 05:16 03/05/21 05:16 BRBOF Brembo $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BRBOF Brembo $0.00 / + (+0.00%) 02/01/21 Exane BNP Paribas Brembo downgraded to Underperform from Neutral at Exane BNP Paribas
Upgrade	Belimo Holding upgraded to Hold from Reduce at Kepler Cheuvreux » 05:15 03/05/21 03/05 05:15 03/05/21 05:15 BLHWF Belimo Holding $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research BLHWF Belimo Holding $0.00 / + (+0.00%) 12/11/20 Berenberg Belimo Holding price target raised to CHF 8,250 from CHF 8,000 at Berenberg 05/26/20 UBS Belimo Holding price target lowered to CHF 5,150 from CHF 5,200 at UBS 03/18/20 Berenberg Belimo Holding upgraded to Buy from Hold at Berenberg
Earnings	ObsEva reports Q4 EPS (32c), consensus (42c) » 05:15 03/05/21 03/05 05:15 03/05/21 05:15 OBSV ObsEva $3.37 / -0.32 (-8.67%) As of December 31, 2020,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Options OBSV ObsEva $3.37 / -0.32 (-8.67%) 01/11/21 ObsEva provides updates on Yselty program 01/04/21 ObsEva appoints David Renas as CFO 12/10/20 ObsEva announces Yselty met primary endpoint in PRIMROSE 1, PRIMROSE 2 studies 11/24/20 ObsEva submits MAA to EMA for Yselty OBSV ObsEva $3.37 / -0.32 (-8.67%) 01/04/21 H.C. Wainwright ObsEva price target lowered to $17 from $23 at H.C. Wainwright 11/09/20 JPMorgan ObsEva downgraded to Underweight from Neutral at JPMorgan 10/05/20 H.C. Wainwright ObsEva price target lowered to $23 from $36 at H.C. Wainwright 07/07/20 Wedbush Selloff in ObsEva shares 'overdone,' says Wedbush OBSV ObsEva $3.37 / -0.32 (-8.67%) 11/05/20 ObsEva reports Q3 EPS (49c), consensus (34c) 30 Oct OBSV ObsEva $3.37 / -0.32 (-8.67%) 12/10/20 Fly Intel: Pre-market Movers OBSV ObsEva $3.37 / -0.32 (-8.67%) 02/16/21 Largest borrow rate increases among liquid names 01/27/21 Largest borrow rate increases among liquid names 01/22/21 Largest borrow rate increases among liquid names

Initiation	Technip Energies initiated with a Buy at Kepler Cheuvreux » 05:15 03/05/21 03/05 05:15 03/05/21 05:15 THNPF Technip Energies $0.00 / + (+0.00%) Kepler Cheuvreux… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research THNPF Technip Energies $0.00 / + (+0.00%) 03/01/21 Exane BNP Paribas Technip Energies initiated with a Neutral at Exane BNP Paribas 03/01/21 Morgan Stanley Technip Energies initiated with an Overweight at Morgan Stanley 02/22/21 Barclays Technip Energies initiated with an Equal Weight at Barclays
Upgrade	Barclays upgraded to Add from Sell at AlphaValue » 05:14 03/05/21 03/05 05:14 03/05/21 05:14 BCS Barclays $9.21 / -0.235 (-2.49%) AlphaValue upgraded… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BCS Barclays $9.21 / -0.235 (-2.49%) 02/18/21 Barclays committed to medium-term targets, including RoTE of over 10% over time 02/18/21 Barclays sees 'meaningful' y/y RoTe improvement in 2021 02/18/21 Barclays declares 1.0p 2020 full year dividend 01/04/21 Penn National CFO David Williams steps down, Felicia Hendrix to succeed BCS Barclays $9.21 / -0.235 (-2.49%) 02/23/21 JPMorgan Barclays price target raised to 190 GBp from 180 GBp at JPMorgan 02/22/21 RBC Capital Barclays price target raised to 150 GBp from 140 GBp at RBC Capital 02/19/21 Deutsche Bank Barclays price target raised to 200 GBp from 180 GBp at Deutsche Bank 01/28/21 Berenberg Barclays price target raised to 180 GBp from 160 GBp at Berenberg BCS Barclays $9.21 / -0.235 (-2.49%) 02/18/21 Barclays reports Q4 group profit before tax GBP0.6B vs. GBP1.1B last year 10/23/20 Barclays reports Q3 group profit before tax GBP 1.1B vs. GBP 0.2B last year 10/13/20 Fly Intel: What to watch in next round of big banks' earnings reports BCS Barclays $9.21 / -0.235 (-2.49%) 03/02/21 French bankers want new EU law to move euro clearing to Frankfurt, Reuters says 02/18/21 Barclays CEO sees staff returning to office this year, Bloomberg reports 12/16/20 Barclays mulls raising bonus pool for traders by roughly 10%, Bloomberg says 10/01/20 Goldman Sachs to buy GM credit-card business for about $2.5B, WSJ reports BCS Barclays $9.21 / -0.235 (-2.49%) 10/23/20 Fly Intel: Wall Street's top stories for Friday 10/23/20 Fly Intel: Wall Street's top stories at midday 10/01/20 Fly Intel: Wall Street's top stories for Thursday 09/11/20 The Intersection: Crypto and Wall Street This Week 03/25/21 REITwise 2021 Virtual Conference BCS Barclays $9.21 / -0.235 (-2.49%) 12/16/20 Barclays call volume above normal and directionally bullish 12/14/20 Unusual call flow in option market yesterday 12/11/20 Short-term premium buyer in Barclays 12/11/20 Unusually active option classes on open December 11th
Upgrade	Henkel upgraded to Hold from Sell at Nord/LB » 05:13 03/05/21 03/05 05:13 03/05/21 05:13 HENKY Henkel $0.00 / + (+0.00%) Nord/LB analyst Thorsten… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Events HENKY Henkel $0.00 / + (+0.00%) 01/12/21 UBS Henkel price target raised to EUR 81 from EUR 80 at UBS 01/05/21 Barclays Barclays trims Henkel Adhesive estimates on slower recovery expectations 12/03/20 JPMorgan Henkel upgraded to Overweight from Neutral at JPMorgan 11/30/20 Commerzbank Henkel upgraded to Buy from Hold at Commerzbank 03/10/21 Global Consumer & Retail Virtual Conference 2021
Hot Stocks	Moderna announces Takeda NDA submission to distribute COVID-19 vaccine in Japan » 05:12 03/05/21 03/05 05:12 03/05/21 05:12 MRNA Moderna $132.21 / +1.01 (+0.77%) , TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) Moderna (MRNA) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 03/04/21 Moderna, IBM to collaborate on COVID vaccine supply, distribution data sharing 03/04/21 GC Pharma to support Moderna distribution of 40M doses of COVID-19 Vaccine 02/25/21 Moderna's chief medical officer Tal Zaks to leave company in late September 02/24/21 Moderna makes new capital investment to boost manufacturing capacity TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 03/03/21 Takeda secures rights to soticlestat from Ovid Therapeutics for $196M upfront 02/26/21 Novavax, Takeda finalize license agreement for COVID-19 vaccine in Japan 02/26/21 Takeda to divest type 2 diabetes portfolio to Teijin Pharma for JPY 133B 02/24/21 Takeda provides update on Novavax, Moderna COVID-19 vaccine candidates in Japan MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 03/01/21 Chardan Moderna price target raised to $182 from $107 at Chardan 02/26/21 Barclays Moderna price target raised to $178 from $169 at Barclays 02/26/21 Brookline Moderna price target raised to $205 from $180 at Brookline 02/25/21 Piper Sandler Moderna transitioning into profitable company, says Piper Sandler TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 03/03/21 RBC Capital Ovid downgraded to Sector Perform at RBC Capital after rally on Takeda deal 01/29/21 Morgan Stanley Morgan Stanley downgrades Jazz to Equal Weight ahead of competitor readout 12/29/20 Needham Needham names Phathom Pharmaceuticals Top Pick for 2021 12/15/20 Needham Phathom Pharmaceuticals price target raised to $55 from $45 at Needham MRNA MRNA Moderna $132.21 / +1.01 (+0.77%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) 19 May MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 03/03/21 Some Catholic bishops advise against certain Covid-19 vaccines, WSJ reports 02/28/21 AstraZeneca sells stake in Moderna for over $1B, The Times reports 02/17/21 Moderna to supply EU with another 150M vaccine doses in 2021, FT reports 02/12/21 FDA tells Moderna it can boost vaccine supply in each vial, NY Times reports TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 10/09/20 Takeda, others testing convalescent plasma treatment in Covid, WSJ reports MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 02/25/21 Fly Intel: Pre-market Movers 02/24/21 Fly Intel: After-Hours Movers 02/12/21 Fly Intel: Wall Street's top stories for Friday 02/12/21 Fly Intel: Wall Street's top stories at midday TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 03/03/21 Fly Intel: Wall Street's top stories for Wednesday 03/03/21 Fly Intel: Wall Street's top stories at midday 03/03/21 Fly Intel: Pre-market Movers 03/16/21 31st Annual Healthcare Virtual Conference MRNA TAK MRNA Moderna $132.21 / +1.01 (+0.77%) 03/01/21 Moderna call volume above normal and directionally bullish 02/01/21 Moderna call volume above normal and directionally bullish 01/25/21 Moderna call volume above normal and directionally bullish 12/17/20 Moderna call volume above normal and directionally bullish TAK Takeda Pharmaceutical $17.45 / -0.25 (-1.41%) 01/22/21 Takeda Pharmaceutical call volume above normal and directionally bullish
Recommendations	Costco price target lowered to $395 from $410 at Baird » 05:07 03/05/21 03/05 05:07 03/05/21 05:07 COST Costco $319.35 / -4.53 (-1.40%) Baird analyst Peter… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options COST Costco $319.35 / -4.53 (-1.40%) 02/03/21 Costco reports January SSS rose 15.9% 01/06/21 Costco December SSS, ex impact from gas, FX rose 10.9% 01/06/21 Costco December E-commerce sales ex gas, FX up 61.6% 11/24/20 Tinley Beverage Company completes full production at Long Beach facility COST Costco $319.35 / -4.53 (-1.40%) 02/03/21 Baird Costco January core comps re-accelerated, says Baird 02/02/21 Cleveland Research Costco U.S. sales slightly improved in January, says Cleveland Research 01/07/21 Deutsche Bank Costco price target raised to $347 from $344 at Deutsche Bank 01/06/21 Baird Costco saw some deceleration in December core comp sales, says Baird COST Costco $319.35 / -4.53 (-1.40%) 03/04/21 Costco reports Q2 EPS $2,14, consensus $2.44 03/04/21 Notable companies reporting after market close 12/10/20 Costco reports Q1 total company comparable sales up 15.4% 12/10/20 Costco reports Q1 EPS $2.62, consensus $2.05 COST Costco $319.35 / -4.53 (-1.40%) 02/26/21 Costco to hike minimum hourly wage to $16 an hour, WSJ reports 12/15/20 FedEx, UPS limiting packages they pick up, creating backlogs, WSJ reports COST Costco $319.35 / -4.53 (-1.40%) 03/04/21 Fly Intel: After-Hours Movers 03/01/21 Fly Intel: What to watch in Target's earnings report 02/26/21 Fly Intel: Wall Street's top stories at midday 12/10/20 Fly Intel: After-Hours Movers COST Costco $319.35 / -4.53 (-1.40%) 12/10/20 Costco options imply 3.8% move in share price post-earnings 11/17/20 Early notable gainers among liquid option names on November 17th 09/24/20 Costco options imply 6.0% move in share price post-earnings 09/24/20 Unusually active option classes on open September 24th

Hot Stocks	Daqo signs three-year, 52,700 MT polysilicon supply agreement with Shangji » 05:07 03/05/21 03/05 05:07 03/05/21 05:07 DQ Daqo New Energy $85.93 / -8.76 (-9.25%) Daqo New Energy announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Events Options DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 03/02/21 Daqo New Energy enters three-year polysilicon supply agreement with Zhonghuan 02/02/21 Daqo New Energy provides update on potential IPO in China 01/13/21 Daqo New Energy falls -6.4% 01/04/21 Daqo New Energy rises 16.1% DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 03/02/21 Roth Capital Daqo New Energy price target raised to $115 from $105 at Roth Capital 02/08/21 Roth Capital Bill could be 'meaningful positive' for solar stocks, says Roth Capital 01/26/21 Roth Capital Daqo New Energy price target raised to $100 from $40 at Roth Capital 12/21/20 Roth Capital ITC/PTC extensions likely included in COVID relief package, says Roth Capital DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 01/08/21 JinkoSolar, Daqo named in report on companies tied to forced labor use, NYT says DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 02/13/21 Charged: Tesla discloses $1.5B bitcoin investment 01/09/21 Charged: Apple self-driving EV said to be years away 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/26/20 Week in review: How Trump's policies moved stocks 03/09/21 Daqo New Energy - DQ DQ Daqo New Energy $85.93 / -8.76 (-9.25%) 02/25/21 Daqo New Energy call volume above normal and directionally bullish 01/11/21 Daqo New Energy put volume heavy and directionally bearish
Recommendations	Fulgent Genetics price target raised to $140 from $135 at Piper Sandler » 05:06 03/05/21 03/05 05:06 03/05/21 05:06 FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 02/16/21 Fulgent Genetics, BioIQ partner on COVID-19 testing programs 12/29/20 Fulgent Genetics extends partnership with NTC DOE and Health 12/17/20 PRA Health partners with Fulgent Genetics to enhance COVID-19 monitoring program 11/18/20 Fulgent Genetics, LANES, LA DHS partner on COVID-19 testing FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 02/03/21 Piper Sandler Fulgent Genetics price target raised to $135 from $100 at Piper Sandler 02/01/21 Oppenheimer Fulgent Genetics price target raised to $130 from $75 at Oppenheimer 02/01/21 Oppenheimer Invitae downgraded to Perform on valuation at Oppenheimer 01/08/21 Credit Suisse Fulgent Genetics downgraded to Underperform from Neutral at Credit Suisse FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 03/04/21 Fulgent Genetics sees FY21 EPS $12.50, consensus $11.55 03/04/21 Fulgent Genetics reports Q4 EPS $6.20, consensus $4.05 11/23/20 Fulgent Genetics raises 2020 revenue view to at least $300M from $235M 11/09/20 Fulgent Genetics reports Q3 EPS$2.08 , consensus 55c FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 09/09/20 Report says U.S. may need 193M coronavirus tests per month, STAT reports FLGT Fulgent Genetics $85.08 / -7.3 (-7.90%) 01/08/21 Fly Intel: Wall Street's top stories for Friday 01/08/21 Fly Intel: Wall Street's top stories at midday 11/09/20 Pfizer, BioNTech lift market as COVID vaccine shows effectiveness 09/22/20 Fly Intel: Wall Street's top stories for Tuesday 03/16/21 31st Annual Healthcare Virtual Conference
Recommendations	Alphatec price target raised to $19 from $17 at Piper Sandler » 05:05 03/05/21 03/05 05:05 03/05/21 05:05 ATEC Alphatec $15.86 / -0.69 (-4.17%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events ATEC Alphatec $15.86 / -0.69 (-4.17%) 02/01/21 Alphatec relocates to new headquarters in Carlsbad 12/17/20 Alphatec to acquire EOS imaging for $79.7M in cash, sees accretion ATEC Alphatec $15.86 / -0.69 (-4.17%) 01/29/21 Piper Sandler Alphatec price target raised to $17 from $12 at Piper Sandler 01/12/21 Piper Sandler Piper remains buyer of Alphatec despite Covid pressures 12/21/20 H.C. Wainwright Alphatec price target raised to $16 from $12 at H.C. Wainwright 12/18/20 Lake Street Alphatec price target raised to $20 from $15 at Lake Street ATEC Alphatec $15.86 / -0.69 (-4.17%) 03/04/21 Alphatec reports Q4 EPS (35c), consensus (21c) 01/12/21 Alphatec sees 2021 revenue approximately $178M, consensus $183.08M 01/12/21 Alphatec sees 2020 revenue $144.8M-$145.1M, consensus $144.13M 01/12/21 Alphatec sees Q4 revenue $43.8M-$44.1M, consensus $43.66M 14 Oct ATEC Alphatec $15.86 / -0.69 (-4.17%) 03/04/21 Fly Intel: After-Hours Movers 10/19/20 Fly Intel: After-Hours Movers 10/13/20 Fly Intel: After-Hours Movers 10/08/20 Fly Intel: Wall Street's top stories for Thursday 03/08/21 Alphatec
Upgrade	Bombardier upgraded to Outperform from Market Perform at BMO Capital » 05:04 03/05/21 03/05 05:04 03/05/21 05:04 BDRBF Bombardier $0.00 / + (+0.00%) BMO Capital analyst Fadi… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BDRBF Bombardier $0.00 / + (+0.00%) 03/04/21 Bombardier targets 2025 total revenues about $7.5B 03/04/21 Bombardier expects business jet deliveries to begin gradual recovery in 2021 03/03/21 Bombardier, Aston Martin sign LOI for custom design services on business jets 02/23/21 Bombardier reports suffering 'limited cybersecurity breach' BDRBF Bombardier $0.00 / + (+0.00%) 02/16/21 Cowen Bombardier downgraded to Underperform from Market Perform at Cowen 02/16/21 Scotiabank Bombardier price target raised to C$0.65 from C$0.55 at Scotiabank 02/12/21 National Bank Bombardier price target lowered to C$0.70 from C$0.80 at National Bank 02/12/21 BMO Capital Bombardier price target raised to C$0.85 from C$0.40 at BMO Capital BDRBF Bombardier $0.00 / + (+0.00%) 02/11/21 Bombardier reports Q4 cont ops EPS (1c), consensus 0c 02/11/21 Bombardier sees FY21 adjusted EBITDA greater than $500M BDRBF Bombardier $0.00 / + (+0.00%) 11/13/20 Disney upgrade among today's top calls on Wall Street 05/06/21 Bombardier - BDRBF
Recommendations	Cutera price target raised to $42 from $38 at Piper Sandler » 05:02 03/05/21 03/05 05:02 03/05/21 05:02 CUTR Cutera $26.21 / -8.715 (-24.96%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events CUTR Cutera $26.21 / -8.715 (-24.96%) 02/17/21 Cutera not providing formal guidance at this time CUTR Cutera $26.21 / -8.715 (-24.96%) 02/18/21 Piper Sandler Cutera price target raised to $38 from $28 at Piper Sandler 11/05/20 Piper Sandler Cutera price target raised to $28 from $22 at Piper Sandler 09/14/20 Stephens Cutera price target raised to $24 from $18 at Stephens 08/07/20 Piper Sandler Cutera should be bought at these 'depressed levels,' says Piper Sandler CUTR Cutera $26.21 / -8.715 (-24.96%) 02/17/21 Cutera reports Q4 EPS 12c, consensus 4c 11/04/20 Cutera reports Q3 EPS (13c), consensus (33c) 17 Apr CUTR Cutera $26.21 / -8.715 (-24.96%) 11/04/20 Fly Intel: After-Hours Movers 03/18/21 Cutera

Upgrade	Fifth Third upgraded to Conviction Buy from Buy at Goldman Sachs » 05:00 03/05/21 03/05 05:00 03/05/21 05:00 FITB Fifth Third $35.57 / -0.36 (-1.00%) Goldman Sachs analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events FITB Fifth Third $35.57 / -0.36 (-1.00%) 02/22/21 Fifth Third CEO Carmichael sells over 155,000 common shares 01/21/21 Fifth Third sees y/y adjusted positive operating leverage in 2H21 01/21/21 Fifth Third sees utilization to remain unchanged for 1H, up 1% in 2H 01/21/21 Fifth Third doesn't see growing investment portfolio in near-term FITB Fifth Third $35.57 / -0.36 (-1.00%) 02/17/21 Citi Citi recommends two new U.S. bank pair trades 01/27/21 Argus Fifth Third price target raised to $35 from $27 at Argus 01/22/21 Wedbush Fifth Third price target raised to $39 from $36 at Wedbush 01/22/21 RBC Capital Fifth Third price target raised to $32 from $27 at RBC Capital FITB Fifth Third $35.57 / -0.36 (-1.00%) 01/21/21 Fifth Third reports Q4 EPS 78c, consensus 69c 10/22/20 Fifth Third reports Q3 EPS 78c, consensus 60c 10/21/20 Notable companies reporting before tomorrow's open 10/21/20 Notable companies reporting before tomorrow's open FITB Fifth Third $35.57 / -0.36 (-1.00%) 01/20/21 Notable companies reporting before tomorrow's open 01/20/21 Notable companies reporting before tomorrow's open 11/21/20 Citizens Financial, Truist among regional bank stocks to grab, Barron's says FITB Fifth Third $35.57 / -0.36 (-1.00%) 09/25/20 Cruise Line upgrades among today's top calls on Wall Street 04/20/21 Fifth Third - FITB 04/13/21 Fifth Third Bancorp
Downgrade	Nikola downgraded to Neutral from Overweight at JPMorgan » 04:56 03/05/21 03/05 04:56 03/05/21 04:56 NKLA Nikola $16.04 / -0.49 (-2.96%) JPMorgan analyst Paul… JPMorgan analyst Paul Coster downgraded Nikola to Neutral from Overweight with a price target of $30, down from $33. Following the Q4 report, which provided investors reassurance that the company is "more focused," much of "good news is now priced in the stock," Coster tells investors in a research note. The analyst believes the story "should heat up again" in to mid- to late-2021 if customer orders get announced and as the first fuel cell electric vehicle prototype "comes to life." Coster calls the downgrade a "tactical call" based on the timing of catalysts. ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NKLA Nikola $16.04 / -0.49 (-2.96%) 02/25/21 Nikola sees delivering first Nikola Tre BEVs to customers during Q4 02/25/21 Nikola CEO says 'necessary changes' made in Q4 to 'refocus and realign' company 02/23/21 Nikola provides update on North American hydrogen fuel-cell vehicle program 01/14/21 Worthington sells it remaining 7.05M shares of Nikola NKLA Nikola $16.04 / -0.49 (-2.96%) 02/01/21 Fly Intel: Top five analyst upgrades 02/01/21 Wedbush Nikola upgraded to Neutral from Underperform at Wedbush 12/28/20 JPMorgan JPMorgan cuts Nikola target but sees 'generally positive' news flow in 2021 12/24/20 Loop Capital Nikola faces 'another setback in a series of setbacks,' says Loop Capital NKLA Nikola $16.04 / -0.49 (-2.96%) 02/25/21 Nikola reports Q4 adjusted EPS (17c), consensus (23c) 02/25/21 Notable companies reporting after market close 11/09/20 Nikola reports Q3 adjusted EPS (16c), consensus (19c) 11/09/20 Notable companies reporting after market close NKLA Nikola $16.04 / -0.49 (-2.96%) 02/26/21 Nikola's review finds several of Milton's claims 'inaccurate,' FT reports 02/16/21 Churchill Capital soars after Reuters says deal with Lucid Motors is close 02/16/21 Churchill Capital Corp IV near deal to bring Lucid Motors public, Reuters says 02/12/21 Nikola, APS electricity deal approved by state regulators, AZ Big Media says NKLA Nikola $16.04 / -0.49 (-2.96%) 02/27/21 Charged: Tesla temporarily halts Model 3 line at CA plant 02/23/21 Fly Intel: Wall Street's top stories at midday 02/23/21 SPACs slide after Lucid Motors confirms anticipated come-public deal 02/20/21 Charged: Analyst sees Apple announcing EV partnership in 2021 03/19/21 Electric Truck Day NKLA Nikola $16.04 / -0.49 (-2.96%) 02/25/21 Nikola options imply 19.4% move in share price post-earnings 02/03/21 Nikola call volume above normal and directionally bullish 01/27/21 Nikola call volume above normal and directionally bullish 01/26/21 Nikola call volume above normal and directionally bullish
Conference/Events	SeaSpine management to meet virtually with BTIG » 04:55 03/05/21 03/05 04:55 03/05/21 04:55 SPNE SeaSpine $17.86 / -0.69 (-3.72%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SPNE SeaSpine $17.86 / -0.69 (-3.72%) 03/01/21 SeaSpine sees 150-200bps of gross margin expansion in FY21 03/01/21 SeaSpine announces full commercial launch of Reef TO Interbody System 02/22/21 SeaSpine announces limited commercial launch of WaveForm system 01/20/21 SeaSpine announces limited commercial launch of Regatta Lateral Plate System SPNE SeaSpine $17.86 / -0.69 (-3.72%) 03/02/21 Canaccord SeaSpine price target raised to $25 from $23 at Canaccord 03/01/21 Piper Sandler SeaSpine price target raised to $28 from $22 at Piper Sandler 01/29/21 Piper Sandler SeaSpine price target raised to $22 from $18 at Piper Sandler 01/11/21 Piper Sandler SeaSpine should be bought on any weakness today, says Piper Sandler SPNE SeaSpine $17.86 / -0.69 (-3.72%) 03/01/21 SeaSpine reports Q4 EPS (37c), consensus (26c) 01/11/21 SeaSpine sees FY20 revenue $154.1M-$154.5M, consensus $155.18M 01/11/21 SeaSpine reports preliminary Q4 revenue $46.2M-$46.2M, consensus $47.27M 11/09/20 SeaSpine reports Q3 EPS (24c), consensus (31c) SPNE SeaSpine $17.86 / -0.69 (-3.72%) 10/19/20 Fly Intel: After-Hours Movers 00:00 Today SeaSpine 03/19/21 SeaSpine
Conference/Events	Zealand Pharma to host research and development virtual day » 04:55 03/05/21 03/05 04:55 03/05/21 04:55 ZEAL Zealand Pharma $30.87 / -0.65 (-2.06%) Research and Development… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 8 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ZEAL Zealand Pharma $30.87 / -0.65 (-2.06%) 12/15/20 Zealand Pharma: Dasiglucagon did not meet primary endpoint in Phase 3 trial 12/15/20 Zealand Pharma announces data from Phase 3 dasiglucagon in CHI trial 11/20/20 Zealand Pharma increases share capital following exercise of employee warrants ZEAL Zealand Pharma $30.87 / -0.65 (-2.06%) 03/10/20 Morgan Stanley Zealand Pharma EPS estimates cut at Morgan Stanley ZEAL Zealand Pharma $30.87 / -0.65 (-2.06%) 11/12/20 Zealand Pharma expects 2020 revenue for V-Go sales DKK150M-DKK175M 11/12/20 Zealand Pharma reports Q3 revenue DKK56.5M vs. DKK9.9M last year 03/11/21 Zealand Pharma - ZEAL 03/27/21 PDFUA Date for Dasiglucagon HypoPal�Rescue Pen 10:00 Today Zealand Pharma
Conference/Events	FBN Securities to hold a virtual tour » 04:55 03/05/21 03/05 04:55 03/05/21 04:55 SIRI Sirius XM $5.79 / -0.09 (-1.53%) , VIAC ViacomCBS $71.87 / +1.01 (+1.43%) , WWE WWE $52.57 / +0.74 (+1.43%) , FWONA Liberty Formula One $39.05 / -0.53 (-1.34%) , BATRA Liberty Braves Group $29.93 / -1 (-3.23%) , LSXMA Liberty SiriusXM $43.38 / -0.99 (-2.23%) , LGF.A Lionsgate $17.09 / +0.32 (+1.91%) Media & Entertainment… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SIRI VIAC WWE FWONA LSXMA LGF.A SIRI Sirius XM $5.79 / -0.09 (-1.53%) 02/02/21 Sirius XM added 909,000 net new self-pay subscribers for FY20 02/02/21 Sirius XM says new car penetration reached approximately 80% in Q4 02/02/21 Sirius XM sees FY21 SiriusXM self-pay net subscriber additions of ~800,000 01/27/21 Sirius XM trading resumes VIAC ViacomCBS $71.87 / +1.01 (+1.43%) 03/04/21 ViacomCBS launches Paramount+ 02/24/21 ViacomCBS unveils Streaming video strategy w/ slate of originals 02/24/21 ViacomCBS announces launch of Avatar Studios 02/24/21 ViacomCBS says new 'Rugrats' series coming to Paramount+ in 2021 WWE WWE $52.57 / +0.74 (+1.43%) 01/25/21 WWE, Peacock announce multi-year streaming agreement 01/25/21 WWE sees FY20 adjusted OIBDA approximately $286M 11/25/20 WWE names Karen Mullane as Controller & Chief Accounting Officer 11/20/20 WWE, Credit One Bank enter multi-year partnership FWONA Liberty Formula One $39.05 / -0.53 (-1.34%) 09/25/20 Liberty Media announces Stefano Domenicali to assume role of CEO of Formula 1 LSXMA Liberty SiriusXM $43.38 / -0.99 (-2.23%) 09/25/20 Liberty Media announces Stefano Domenicali to assume role of CEO of Formula 1 LGF.A Lionsgate $17.09 / +0.32 (+1.91%) 03/02/21 Lionsgate and STARZ close output deal 02/26/21 Lionsgate, Sony Pictures enter multi-year distribution agreement 12/22/20 Sony Pictures CEO says 'don't think' will move to 'day and date' film releases 12/02/20 Starz announces launch of direct to consumer 'Lionsgate Play' in India SIRI VIAC WWE FWONA BATRA LSXMA LGF.A SIRI Sirius XM $5.79 / -0.09 (-1.53%) 02/03/21 Citi Tax sharing agreement 'very bullish' for Liberty SiriusXM, says Citi 01/28/21 Fly Intel: Top five analyst downgrades 01/28/21 Credit Suisse Sirius XM downgraded to Neutral after rally at Credit Suisse 01/27/21 Credit Suisse Sirius XM downgraded to Neutral from Outperform at Credit Suisse VIAC ViacomCBS $71.87 / +1.01 (+1.43%) 03/01/21 Cowen ViacomCBS price target raised to $46 from $39 at Cowen 02/25/21 Fly Intel: Pre-market Movers 02/25/21 Loop Capital ViacomCBS cut to Sell at Loop Capital with profitability from streaming unclear 02/25/21 Needham ViacomCBS price target raised to $80 from $55 at Needham WWE WWE $52.57 / +0.74 (+1.43%) 02/05/21 Needham WWE price target raised to $65 from $50 at Needham 01/27/21 MKM Partners WWE price target raised to $65 from $60 at MKM Partners 01/26/21 Benchmark WWE price target raised to $62 from $55 at Benchmark 01/19/21 Evercore ISI Evercore ISI upgrades 'COVID recovery idea' WWE to Outperform FWONA Liberty Formula One $39.05 / -0.53 (-1.34%) 03/04/21 Citi Liberty Formula One price target raised to $46 from $40 at Citi 12/10/20 Guggenheim Liberty Formula One initiated with a Buy at Guggenheim 11/11/20 Pivotal Research Liberty Formula One price target raised to $50 from $47 at Pivotal Research 10/01/20 Berenberg Liberty Formula One initiated with a Buy at Berenberg BATRA Liberty Braves Group $29.93 / -1 (-3.23%) LSXMA Liberty SiriusXM $43.38 / -0.99 (-2.23%) 02/03/21 Citi Tax sharing agreement 'very bullish' for Liberty SiriusXM, says Citi 01/11/21 Barclays Liberty SiriusXM upgraded to Overweight from Equal Weight at Barclays 12/17/20 Morgan Stanley Liberty SiriusXM price target raised to $52 from $45 at Morgan Stanley 11/19/20 Deutsche Bank Liberty SiriusXM price target raised to $69 from $64 at Deutsche Bank LGF.A Lionsgate $17.09 / +0.32 (+1.91%) 02/08/21 Deutsche Bank Lionsgate price target raised to $16 from $12 at Deutsche Bank 02/05/21 RBC Capital Lionsgate price target raised to $13 from $7 at RBC Capital 01/28/21 Macquarie Lionsgate price target raised to $18 from $12 at Macquarie 11/10/20 Deutsche Bank Lionsgate price target raised to $12 from $10 at Deutsche Bank SIRI VIAC WWE FWONA LGF.A SIRI Sirius XM $5.79 / -0.09 (-1.53%) 02/02/21 Sirius XM sees FY21 adjusted EBITDA approximately $2.575B 02/02/21 Sirius XM reports Q4 EPS (16c), consensus 1c 02/01/21 Notable companies reporting before tomorrow's open 02/01/21 Notable companies reporting before tomorrow's open VIAC ViacomCBS $71.87 / +1.01 (+1.43%) 02/24/21 ViacomCBS reports Q4 EPS $1.04, consensus $1.02 02/24/21 Notable companies reporting after market close 11/06/20 ViacomCBS reports Q3 adj. EPS 91c, consensus 80c 11/05/20 Notable companies reporting before tomorrow's open WWE WWE $52.57 / +0.74 (+1.43%) 02/04/21 WWE reports Q4 adjusted EPS 24c, consensus 30c 10/29/20 WWE reports Q3 adjusted EPS 56c, consensus 38c FWONA Liberty Formula One $39.05 / -0.53 (-1.34%) 02/26/21 Liberty Media reports Q4 revenue $485M, consensus $604.33M 11/05/20 Liberty Media reports Q3 EPS 6c, consensus (4c) LGF.A Lionsgate $17.09 / +0.32 (+1.91%) 02/04/21 Lionsgate reports Q3 adjusted EPS 21c, consensus (11c) 11/05/20 Lionsgate reports Q2 adjusted EPS 33c, consensus (3c) 11/05/20 Notable companies reporting after market close 25 Mar SIRI VIAC WWE LGF.A SIRI Sirius XM $5.79 / -0.09 (-1.53%) 01/15/21 Apple to challenge Spotify with podcast subscription service, Information says 10/06/20 Sirius XM close to contract renewal deal with Howard Stern, Bloomberg says VIAC ViacomCBS $71.87 / +1.01 (+1.43%) 03/03/21 Amazon in talks to carry 'many' exclusive NFL games on Prime Video, WSJ says 02/11/21 ViacomCBS working on '60 Minutes' spinoff for Paramount+, Bloomberg says 02/01/21 Facebook hires Henry Moniz as chief compliance officer, BI reports 01/26/21 CBS suspends executives accused of creating hostile work environment, NYT says WWE WWE $52.57 / +0.74 (+1.43%) 11/20/20 WWE agrees to multi-year partnership deal with Credit One, Sportico reports LGF.A Lionsgate $17.09 / +0.32 (+1.91%) 12/10/20 Disney, NBCUniversal unlikely to follow WarnerMedia's 2021 media plan, CNBC says 11/05/20 Lionsgate laying off about 15% of motion picture unit staff, Variety says SIRI VIAC WWE LGF.A SIRI Sirius XM $5.79 / -0.09 (-1.53%) 02/02/21 Fly Intel: Pre-market Movers 01/27/21 Fly Intel: What to watch in Apple earnings report 01/15/21 Fly Intel: Wall Street's top stories for Friday 01/15/21 Spotify plunges after downgrade, report of Apple podcast ambitions VIAC ViacomCBS $71.87 / +1.01 (+1.43%) 02/25/21 Lowe's, Square upgrades among today's top calls on Wall Street 02/04/21 Best Buy upgrade, ViacomCBS downgrade among today's top calls on Wall Street 01/28/21 Tesla downgrade, Twitter upgrade among today's top calls on Wall Street 01/27/21 Nokia soars but company 'not aware' of apparent reason for trading activity WWE WWE $52.57 / +0.74 (+1.43%) 02/04/21 Fly Intel: After-Hours Movers 01/25/21 Fly Intel: Pre-market Movers LGF.A Lionsgate $17.09 / +0.32 (+1.91%) 11/05/20 Fly Intel: After-Hours Movers 10/04/20 Box Office Battle: 'Tenet' stays on top as box office recovery collapses 09/27/20 Box Office Battle: 'Tenet' stays on top, nears $300M globally 09/25/20 Box Office Battle: 'Tenet' expected to remain #1, other films delay openings 03/11/21 Media 00:00 Today Media & Entertainment Virtual Tour 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference 04/28/21 Sirius XM - SIRI SIRI VIAC SIRI Sirius XM $5.79 / -0.09 (-1.53%) 03/04/21 Sirius XM call volume above normal and directionally bullish 01/25/21 Sirius XM call volume above normal and directionally bullish 01/05/21 Unusual call flow in option market yesterday 01/04/21 Sirius XM call volume above normal and directionally bullish VIAC ViacomCBS $71.87 / +1.01 (+1.43%) 02/18/21 Early notable gainers among liquid option names on February 18th 02/04/21 ViacomCBS Class B put volume heavy and directionally bearish 12/14/20 ViacomCBS Class B put volume heavy and directionally bearish 12/11/20 ViacomCBS Class B call volume above normal and directionally bullish

Events

Earnings calls, analyst events, roadshows and more

CLLS
Today at 08:00

Cellectis - CLLS Conference Calls
EGLE
Today at 08:00

Eagle Bulk Shipping - EGLE Conference Calls
GSX
Today at 08:00

GSX Techedu - GSX Conference Calls
BIG
Today at 08:00

Big Lots - BIG Conference Calls
COE
Today at 08:00

China Online Education - COE Conference Calls
IVA
Today at 08:00

Inventiva - IVA Conference Calls
Today at 08:00

European Capital Goods Industry Meetings
Today at 08:30

Employment Situation--Average Hourly Earnings M/M: February 2021 Government Event
Today at 08:30

Employment Situation: Non-Farm Payrolls M/M: February 2021 Government Event
Today at 08:30

Employment Situation--Average Hourly Earnings Y/Y: February 2021 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC Priced at: $28.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLRX X SLRX Salarius Pharmaceuticals Secondary Managers: Ladenburg Priced at: $1.3685 14.615M Shares VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James Priced at: $34.00 2.206M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR Priced at: $11.50 4.35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham Priced at: $31.00 4.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SUI X SUI Sun Communities Secondary Managers: Citi, BofA, BMO Capital, JPMorgan & RBC Capital Priced at: $140.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan $46.50 3.9M Shares FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan $73.25 4.65M Shares
Thurs	AMRC X AMRC Ameresco Spot Secondary Managers: BofA & Oppenheimer, Baird, Canaccord, Guggenheim, William Blair $44.00-46.25 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

NASDAQ market internals summary

TODAY'S FREE FLY STORIES

Get Full Fly Access